Transition metal compounds as cancer radiosensitizers
The concomitant administration of ionising radiation (IR) in the form of external beam radiotherapy or targeted radionuclide therapy (TRT) alongside radiosensitizing small molecules is a highly successful strategy for the treatment of cancer. The major clinical impact of the radiosensitizing platinu...
Main Authors: | Gill, M, Vallis, K |
---|---|
Format: | Journal article |
Published: |
Royal Society of Chemistry
2018
|
Similar Items
-
A ruthenium polypyridyl intercalator stalls DNA replication forks, radiosensitizes human cancer cells and is enhanced by Chk1 inhibition
by: Gill, M, et al.
Published: (2016) -
Radiosensitivity of colorectal cancer to 90Y and the radiobiological implications for radioembolisation therapy
by: Lee, B, et al.
Published: (2019) -
111In-labelled polymeric nanoparticles incorporating a ruthenium-based radiosensitizer for EGFR-targeted combination therapy in oesophageal cancer cells
by: Gill, M, et al.
Published: (2018) -
Enhancement of radiosensitization by metal-based nanoparticles in cancer radiation therapy
by: Xiang-Yu Su, et al.
Published: (2014-06-01) -
Megavoltage radiosensitization of gold nanoparticles on a Glioblastoma Cancer Cell Line using a clinical platform
by: Kazmi, F, et al.
Published: (2020)